-+ 0.00%
-+ 0.00%
-+ 0.00%

STOKE THERAPEUTICS APPOINTS BO CUMBO TO ITS BOARD OF DIRECTORS, ENHANCING COMMERCIAL EXPERTISE AS THE COMPANY ADVANCES ZOREVUNERSEN DEVELOPMENT TOWARD POTENTIAL FDA APPROVAL AND COMMERCIALIZATION

Reuters·09/23/2026 20:01:00

Please log in to view news